Why Direxion Korea Bull 3X (KORU) fell 1.86%
Direxion Korea Bull 3X (KORU) fell 1.86% on August 28, 2026 — Samsung biotech rights issue weighs sector.
What happened
Direxion Korea Bull 3X fell 1.9% as the Korea Tech theme retreated 2.5% on the group median, with Samsung Biologics' W3tr rights offering adding sector-wide sentiment pressure.
Why it moved
As a 3x leveraged long bet on Korean equities, KORU moves with its underlying index; the Korea Tech selloff — driven by easing HBM supply concerns, valuation fatigue, and the Biologics dilution overhang — translates…
Why it matters
Korea Tech's three-month reversal is repricing structural risk in the AI supercycle narrative: supply constraints that justified the rally are loosening, and near-term capex optimism is fading.
What would break the thesis
If Korea Tech stabilizes and HBM demand confirms at elevated levels despite easing supply concerns, the theme can re-accelerate and leverage will work the other way — KORU could reverse sharply upward.
Sources
- Samsung Biologics to raise W3tr via rights offering — Korea Herald